L. Caballeria

S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial.

J. Rodés, J. Caballería, J. Mato, 1999, Journal of hepatology.

Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis

J. Rodés, R. Deulofeu, J. Caballería, 1996, Hepatology.

Zinc administration improves gastric alcohol dehydrogenase activity and first-pass metabolism of ethanol in alcohol-fed rats.

J. Rodés, R. Deulofeu, J. Caballería, 1997, Alcoholism, clinical and experimental research.

Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial. UDCA-Cooperative Group from the Spanish Association for the Study of the Liver.

L. Rodrigo, D. Rodríguez-Martínez, A. Parés, 2000, Journal of hepatology.

Carbohydrate-deficient transferrin as a marker of alcohol consumption in male patients with liver disease.

J. Rodés, R. Deulofeu, J. Caballería, 1997, Alcoholism, clinical and experimental research.

Metadoxine accelerates fatty liver recovery in alcoholic patients: results of a randomized double-blind, placebo-control trial. Spanish Group for the Study of Alcoholic Fatty Liver.

J. Rodés, J. Caballería, L. Rodrigo, 1998, Journal of hepatology.

Collagen type Ialpha1 and vitamin D receptor gene polymorphisms and bone mass in primary biliary cirrhosis.

F. Rivera, F. Pons, N. Guañabens, 2001, Hepatology.

[Prevalence and factors associated to the presence of fatty liver in apparently healthy adult men].

R. Tresserras, J. Rodés, J. Caballería, 2000, Medicina clinica.